‘’We welcome the EHDS as we believe it can contribute to the improvement of disease prevention, patient-oriented healthcare and better treatment options. The EHDS must be used for the ‘public good’, therefore we urge European policymakers to set a clear and transparent legal framework, providing criteria about legitimates purposes and legitimate users and contributors. A […]

On 8 April, the CPME Executive Committee adopted a statement addressing certain particularities of interoperability in the healthcare sector, offering few recommendations. European doctors stress that an interoperability policy in the healthcare sector needs to be driven by specific fundamental principles, such as security by design, privacy by design, medical confidentiality and ethical principles. Moreover, […]

On 8 April 2021, the CPME Executive Committee adopted a response to the Public Consultation on Shopping for alcoholic and tobacco products in another EU country.

”With the Pharmaceutical Strategy, the European Commission sets the right course of action towards ensuring patients’ access to affordable medicines. When implementing it, European doctors can bring valuable knowledge and experience to the discussion on how to reform the EU pharmaceutical sector to better serve patients and populations” says CPME Vice President Dr Christiaan Keijzer. […]

 “During the COVID-19 pandemic, telemedicine was key in continuing patient care, for example by home-monitoring, teletriage and remote consultations. However, while we encourage the use of telemedicine as an additional tool to the medical profession, we consider face-to-face consultations as the gold standard ‘’says CPME Vice-President, Dr Raymond Walley. Full press release available here.

New CPME position on Commission’s Proposal for a Regulation on cross-border threats to health, available here. New CPME position on Commission’s Proposal for a Regulation amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control, available here. New CPME position on Commission’s Proposal for a Regulation on a reinforced role for […]

On 20 March, CPME adopted a policy on the EHDS with a focus on health research and policy making. CPME welcomes the EHDS as it can contribute to improve disease prevention, patient-oriented health care and better treatment options. CPME stresses that the EHDS should have a clear legal framework, based on the GDPR and transparent […]

On 20 March 2021, the CPME board adopted the new CPME policy on Telemedicine, accessible here. With this paper, CPME intends to highlight that telemedicine has the potential to be used in a number of clinical scenarios, discussing dome of the advantages of its use as well as potential risks. CPME furthermore underlines that telemedicine […]

On 20 March 2021, European doctors from 38 National Medical Associations met online for the biannual General Assembly and Board meetings of the Standing Committee of European Doctors (CPME).“I would like to thank all CPME members for their fruitful exchanges on recent health policy developments. The new policies tackle key questions: how to better manage […]

On 20 March 2021, the CPME Board adopted the ’CPME Position on the Commission’s Proposal for a Regulation amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control’ (CPME 2021/025 FINAL).